127 related articles for article (PubMed ID: 15176923)
1. [Anti-hypertensive effect of eprosartan in diabetic patients].
Robles NR; Velasco J; Jiménez Pérez JL; Alonso FJ; Blanco J; Masot J; Matilla C; Nieto J; Romero F; Gamero MJ
An Med Interna; 2004 May; 21(5):223-6. PubMed ID: 15176923
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of eprosartan in diabetic hypertensive patients.
Robles NR; Martín-Agueda B; López-Muñoz F; Alamo C;
Eur J Intern Med; 2008 Jan; 19(1):27-31. PubMed ID: 18206598
[TBL] [Abstract][Full Text] [Related]
3. Ambulatory monitoring of systolic hypertension in the elderly: Eprosartan/hydrochlorothiazide compared with losartan/hydrochlorothiazide (INSIST trial).
Ambrosioni E; Bombelli M; Cerasola G; Cipollone F; Ferri C; Grazioli I; Leprotti C; Mancia G; Melzi G; Mugellini A; Mulè G; Palasciano G; Salvetti A; Trimarco B
Adv Ther; 2010 Jun; 27(6):365-80. PubMed ID: 20556561
[TBL] [Abstract][Full Text] [Related]
4. A double blind randomized trial to compare the effects of eprosartan and enalapril on blood pressure, platelets, and endothelium function in patients with essential hypertension.
Leu HB; Charng MJ; Ding PY
Jpn Heart J; 2004 Jul; 45(4):623-35. PubMed ID: 15353873
[TBL] [Abstract][Full Text] [Related]
5. Eprosartan-based hypertension therapy, systolic arterial blood pressure and cognitive function: analysis of Middle East data from the OSCAR study.
Radaideh GA; Choueiry P; Ismail A; Eid E; Berrou JP; Sedefdjian A; Sévenier F; Pathak A
Vasc Health Risk Manag; 2011; 7():491-5. PubMed ID: 21915165
[TBL] [Abstract][Full Text] [Related]
6. Effects of telmisartan compared with eprosartan on blood pressure control, glucose metabolism and lipid profile in hypertensive, type 2 diabetic patients: a randomized, double-blind, placebo-controlled 12-month study.
Derosa G; Ragonesi PD; Mugellini A; Ciccarelli L; Fogari R
Hypertens Res; 2004 Jul; 27(7):457-64. PubMed ID: 15302981
[TBL] [Abstract][Full Text] [Related]
7. The angiotensin receptor blocker eprosartan mesylate reduces pulse pressure in isolated systolic hypertension.
Teitelbaum I; Chilvers M; Reiz RJ
Can J Cardiol; 2004 Oct; 20 Suppl C():11C-16C. PubMed ID: 16807618
[TBL] [Abstract][Full Text] [Related]
8. Effects of eprosartan on diastolic function and neurohormones in patients with hypertension and diastolic dysfunction.
Voors AA; van de Wal RM; Hartog JW; Vijn RG; Hummel YM; Plokker TW; van Veldhuisen DJ; Jaarsma W
Cardiovasc Drugs Ther; 2010 Feb; 24(1):33-40. PubMed ID: 20229056
[TBL] [Abstract][Full Text] [Related]
9. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
Levine B
Curr Med Res Opin; 2001; 17(1):8-17. PubMed ID: 11464450
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and safety of eprosartan on pulse pressure for the treatment of hypertensive patients.
Robles NR; Martín-Agueda B; López-Muñoz F; Alamo C;
Int J Clin Pract; 2005 Apr; 59(4):478-84. PubMed ID: 15853868
[TBL] [Abstract][Full Text] [Related]
11. Eprosartan mesylate effectively reduces systolic and diastolic blood pressure in a Canadian primary care setting.
Conter HS; McKay DW; Reiz RJ
Can J Cardiol; 2004 Oct; 20 Suppl C():6C-10C. PubMed ID: 16807617
[TBL] [Abstract][Full Text] [Related]
12. Effect of eprosartan and enalapril in the treatment of black hypertensive patients: subgroup analysis of a 26-week, double-blind, multicentre study. Eprosartan Multinational Study Group.
Levine B
Curr Med Res Opin; 1999; 15(1):25-32. PubMed ID: 10216808
[TBL] [Abstract][Full Text] [Related]
13. Effect of eprosartan and enalapril in the treatment of elderly hypertensive patients: subgroup analysis of a 26-week, double-blind, multicentre study. Eprosartan Multinational Study Group.
Argenziano L; Trimarco B
Curr Med Res Opin; 1999; 15(1):9-14. PubMed ID: 10216806
[TBL] [Abstract][Full Text] [Related]
14. Effect of long-term eprosartan versus enalapril antihypertensive therapy on left ventricular mass and coronary flow reserve in stage I-II hypertension. Eprosartan Study Group.
Diamond JA; Gharavi A; Roychoudhury D; Machac J; Henzlova MJ; Travis A; Phillips RA
Curr Med Res Opin; 1999; 15(1):1-8. PubMed ID: 10216805
[TBL] [Abstract][Full Text] [Related]
15. Effects of eprosartan versus enalapril in hypertensive patients on the renin-angiotensin-aldosterone system and safety parameters: results from a 26-week, double-blind, multicentre study. Eprosartan Multinational Study Group.
Gavras I; Gavras H
Curr Med Res Opin; 1999; 15(1):15-24. PubMed ID: 10216807
[TBL] [Abstract][Full Text] [Related]
16. Effect of eprosartan-based antihypertensive therapy on coronary heart disease risk assessed by Framingham methodology in Canadian patients: results of the POWER survey.
Petrella RJ; Tremblay G; De Backer G; Gill DP;
Vasc Health Risk Manag; 2014; 10():63-74. PubMed ID: 24493928
[TBL] [Abstract][Full Text] [Related]
17. Once-daily eprosartan mesylate in the treatment of elderly patients with isolated systolic hypertension: data from a 13-week double-blind, placebo-controlled, parallel, multicenter study.
Punzi HA; Punzi CF
J Hum Hypertens; 2004 Sep; 18(9):655-61. PubMed ID: 15042114
[TBL] [Abstract][Full Text] [Related]
18. The efficacy and tolerance of one or two daily doses of eprosartan in essential hypertension. The Eprosartan Multinational Study Group.
Hedner T; Himmelmann A
J Hypertens; 1999 Jan; 17(1):129-36. PubMed ID: 10100104
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects of telmisartan and eprosartan on insulin sensitivity in the treatment of overweight hypertensive patients.
Fogari R; Zoppi A; Ferrari I; Mugellini A; Preti P; Lazzari P; Derosa G
Horm Metab Res; 2009 Dec; 41(12):893-8. PubMed ID: 19708000
[TBL] [Abstract][Full Text] [Related]
20. Antihypertensive effects and safety of eprosartan: a meta-analysis of randomized controlled trials.
Xu FY; Yang B; Shi D; Li H; Zou Z; Shi XY
Eur J Clin Pharmacol; 2012 Feb; 68(2):195-205. PubMed ID: 21881888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
